Dual Inhibition of EGFR and IGF-1R Signaling Leads to Enhanced Antitumor Efficacy against Esophageal Squamous Cancer

Both the epidermal growth factor receptor (EGFR) and insulin-like growth factor 1 receptor (IGF-1R) have been implicated in the development of cancers, and the increased expression of both receptors has been observed in esophageal cancer. However, the tyrosine kinase inhibitors of both receptors hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Jia, Guo, Zanzan, Zhang, Haoqi, Guo, Rongqi, Zhu, Xiaofei, Guo, Xiaofang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499412/
https://www.ncbi.nlm.nih.gov/pubmed/36142299
http://dx.doi.org/10.3390/ijms231810382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499412/
https://www.ncbi.nlm.nih.gov/pubmed/36142299
http://dx.doi.org/10.3390/ijms231810382

Ejemplares similares